After the situation in Europe, the Astrazeneca vaccine, the supply of which is suspended in many countries, has received a new name. She was renamed Vaxzervia, reported on the website of the Medical Products of Sweden.
The regulator noted that the change of the name does not bear with them changes from other drug parameters. At the same time, the labeling and packaging of the new product may differ.
The last country suspended the use of vaccinations, became Canada. There it will cease to apply for the vaccination of people over 55 years old. According to Canadian specialists, the probability of thrombosis in the Astrazeneca vaccinated preparation is 1 to 100 thousand. It was previously believed that such an effect was observed in one of the millions of cases.
A number of European countries have been suspended or banned by Astrazeneca vaccination after discovery of thrombosis in the intimidated patients. At the same time, the creators of the drug insist on its safety. The company stressed that the study of health over 17 million after vaccination showed the absence of increased risk of pulmonary artery embolism, deep veins thrombosis or thrombocytopenia.